INTASYL

Serial Number 88571383
Registration 7139368
700

Registration Progress

Application Filed
Aug 8, 2019
Under Examination
Approved for Publication
Published for Opposition
Jun 23, 2020
Registered
Aug 15, 2023

Basic Information

Serial Number
88571383
Registration Number
7139368
Filing Date
August 8, 2019
Registration Date
August 15, 2023
Published for Opposition
June 23, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 15, 2023
Registration
Registered
Classes
005

Rights Holder

Phio Pharmaceuticals Corp.

03
Address
257 Simarano Drive, Suite 101
Marlborough, MA 01752

Ownership History

Phio Pharmaceuticals Corp.

Original Applicant
03
Marlborough, MA

Phio Pharmaceuticals Corp.

Original Applicant
03
Marlborough, MA

Phio Pharmaceuticals Corp.

Owner at Publication
03
Marlborough, MA

Phio Pharmaceuticals Corp.

Owner at Publication
03
Marlborough, MA

Phio Pharmaceuticals Corp.

Original Registrant
03
Marlborough, MA

Phio Pharmaceuticals Corp.

Original Registrant
03
Marlborough, MA

Legal Representation

Attorney
Sarah Anne Keefe

Application History

50 events
Date Code Type Description
Aug 15, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 15, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 15, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 15, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 14, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 14, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 13, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 13, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 12, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jul 12, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jul 6, 2023 IUAF S USE AMENDMENT FILED
Jul 6, 2023 EISU I TEAS STATEMENT OF USE RECEIVED
Jul 6, 2023 IUAF S USE AMENDMENT FILED
Jul 6, 2023 EISU I TEAS STATEMENT OF USE RECEIVED
Mar 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2023 EX5G S SOU EXTENSION 5 GRANTED
Feb 28, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 28, 2023 EX5G S SOU EXTENSION 5 GRANTED
Feb 28, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 10, 2023 EXT5 S SOU EXTENSION 5 FILED
Feb 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 10, 2023 EXT5 S SOU EXTENSION 5 FILED
Feb 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 17, 2022 EXT4 S SOU EXTENSION 4 FILED
Aug 17, 2022 EX4G S SOU EXTENSION 4 GRANTED
Aug 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 17, 2022 EXT4 S SOU EXTENSION 4 FILED
Aug 17, 2022 EX4G S SOU EXTENSION 4 GRANTED
Aug 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 7, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 7, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 7, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 7, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 7, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 7, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 11, 2022 EX3G S SOU EXTENSION 3 GRANTED
Feb 11, 2022 EXT3 S SOU EXTENSION 3 FILED
Feb 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 11, 2022 EX3G S SOU EXTENSION 3 GRANTED
Feb 11, 2022 EXT3 S SOU EXTENSION 3 FILED
Feb 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 1, 2022 DOCK D ASSIGNED TO EXAMINER
Feb 1, 2022 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
First Use Anywhere: Jun 27, 2022
First Use in Commerce: Jun 27, 2022

Classification

International Classes
005